Mogamulizumab-associated rashes, their presentation and prognostic significance: a single-centre retrospective case series analysis

J Eur Acad Dermatol Venereol. 2023 May;37(5):e615-e617. doi: 10.1111/jdv.18831. Epub 2023 Jan 25.

Authors

Alessandro Pileri^{1

2}, Giacomo Clarizio^{1

2}, Corrado Zengarini^{1

2}, Beatrice Casadei², Elena Sabattini^{3

4}, Claudio Agostinelli^{2

3}, Pier Luigi Zinzani^{3

4}

Affiliations

¹ Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
³ Hematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
⁴ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.

PMID: 36545932
DOI: 10.1111/jdv.18831

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Exanthema* / chemically induced
Humans
Leukemia-Lymphoma, Adult T-Cell*
Prognosis
Retrospective Studies

Substances

mogamulizumab
Antibodies, Monoclonal, Humanized